Director/PDMR Shareholding - LTIP and DBP awards

Summary by AI BETAClose X

Oxford Nanopore Technologies plc announced the vesting of 50% of Deferred Bonus Plan awards for Nicholas Keher, its Chief Financial Officer, on April 11, 2026, resulting in the issuance of 48,920 new ordinary shares on April 14, 2026. Subsequently, Mr. Keher sold 22,993 of these shares on the London Stock Exchange for £1.0848 each, totaling £24,942.94, to cover tax liabilities arising from the award vesting.

Disclaimer*

Oxford Nanopore Technologies plc
15 April 2026
 

15 April 2026

Oxford Nanopore Technologies plc (the "Company")

Vesting of DBP awards; Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company announces the following transactions in connection with certain of its employee share plans.

Vesting of 2024 and 2025 Deferred Bonus Plan 2021 ("DBP") awards

On 11 April 2026, 50% of the DBP awards made to Nicholas Keher, a person discharging managerial responsibilities ("PDMR"), in 2024 and 2025 vested and the awards were satisfied through the issue of new ordinary shares of £0.0001 each ("Shares") on 14 April 2026 as follows:

Nicholas Keher (Director)

48,920


Nicholas Keher then sold sufficient Shares to meet his tax liabilities in respect of the vesting of his award.

 

Nicholas Keher - Issue of new shares under the DBP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nicholas Keher

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Vesting of awards made under the Deferred Bonus Plan 2021

c)

Price(s) and volumes(s)

 

Price(s)

Volume(s)

Nil

48,920

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

48,920

Nil

e)

Date of the transaction

14 April 2026

f)

Place of the transaction

London Stock Exchange (XLON)

 

Nicholas Keher - Sale of new shares under the DBP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nicholas Keher

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Sale

c)

Price(s) and volumes(s)

 

Price(s)

Volume(s)

£1.0848

22,993

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

22,993

£24,942.94

e)

Date of the transaction

14 April 2026

f)

Place of the transaction

London Stock Exchange (XLON)

[ENDS]

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

OxfordNanoporeTechnologies@teneo.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100